CoreCap Advisors’s IDEAYA Biosciences IDYA Stock Holding History

CoreCap Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.24K	Hold	60	–	–	﹤0.01%	2509
2026 Q1	$2K	Hold	60	–	–	﹤0.01%	2414
2025 Q4	$2.07K	Buy	+60	New	+$1.91K	﹤0.01%	2469

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

CoreCap Advisors's IDYA Position: Q2 2026 in Review

CoreCap Advisors held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 60 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

CoreCap Advisors first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

CoreCap Advisors held 60 shares of IDEAYA Biosciences worth $2.24K as of Q2 2026.
CoreCap Advisors left its IDEAYA Biosciences share count unchanged in Q2 2026.
IDEAYA Biosciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2509 holding.
CoreCap Advisors first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.